Publications by authors named "Chiao-An Luo"

Claim this Profile
M
Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and meta-analysis.
Chih-Chen Tzang, Pei-Hsun Wu, Chiao-An Luo, Zi-Ting Chen, Yi-Ting Lee

EClinicalMedicine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of PARP inhibitors in ovarian cancer: An umbrella review of systematic reviews and meta-analyses.
Chih-Chen Tzang, Ewen Shengyao Huang, Hui-Wen Wu, Wei-Chen Lin, Yi Ting Lee, Chiao-An Luo

Crit Rev Oncol Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of PARP inhibitors in breast cancer: An umbrella review of systematic reviews and meta-analyses.
Chih-Chen Tzang, Hui-Wen Wu, Chiao-An Luo, Ewen Shengyao Huang, Wei-Chen Lin

Crit Rev Oncol Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of PARP inhibitors in prostate cancer: An umbrella review of systematic reviews and meta-analyses.
Chih-Chen Tzang, Hui-Wen Wu, Chiao-An Luo, Yong-Tang Li, Yuan-Fu Kang

Crit Rev Oncol Hematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of human Parvovirus B19 infection on autoimmunity and autoimmune diseases.
Chih-Chen Tzang, Liang-Yun Chi, Chen-Yu Lee, Zi-Yi Chang, Chiao-An Luo

Int Immunopharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis